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Purpose
Polycystic ovary syndrome (PCOS) is the most common
female endocrine disorder, affecting 6-18% of women of
reproductive age. Irregular periods are a hallmark symp-
tom of PCOS and whilst Chinese herbal medicine
(CHM) has historically been used as an effective treat-
ment for irregular periods, this requires further investi-
gation in randomised controlled trials (RCTs). To
ensure that the methods used within an RCT reflects
Chinese herbal methods used in clinical practice, a
study was proposed to establish good practice guidelines
in the treatment of PCOS through achieving consensus
amongst a group of Chinese medicine herbalists.
Methods
The Delphi method was used involving in-depth inter-
views with a purposive sample of 11 expert Chinese
medicine herbalists. Interview data was analysed using
thematic and framework analysis to formulate Delphi
questionnaire items. Experts were then distributed the
questionnaire online and asked to rate their agreement
with each questionnaire item on a 7-point Likert scale.
Consensus was defined a priori as a mean Likert scale
score of 5 or more. Questionnaire items not reaching
consensus were re-distributed to experts for re-consid-
eration via a second and a third and final round of ques-
tionnaires where necessary.
Results
Preliminary results suggest that consensus exists
amongst experts regarding common diagnostic cate-
gories, treatment strategies used, appropriate dosage and
appropriate duration of treatment to observe a clinical
effect.
Conclusion
The preliminary results suggest that consensus can be
achieved at least within the core aspects of Chinese her-
bal medicine treatment for PCOS. This methodology is
vital in the development of rigorous RCTs for CHM and
the outcome and principles of good practice guidelines
for PCOS will be presented at the conference.
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